Health Care

Shares in Vertex Pharmaceuticals Incorporated (VRTX) Acquired by Elkhorn Investments LLC

Shares in Vertex Pharmaceuticals Incorporated (VRTX) Acquired by Elkhorn Investments LLC

Janney Montgomery Scott initiated coverage on Vertex Pharmaceuticals in a report on Thursday, November 17th. They issued a "buy" rating and a $105.00 price objective on the stock.

09/13/2016 - Raymond James began new coverage on Vertex Pharmaceuticals Incorporated giving the company a "market perform" rating.

03/06/2017 - Vertex Pharmaceuticals Incorporated had its "outperform" rating reiterated by analysts at Robert W. Baird. Jefferies Group LLC restated a "buy" rating on shares of Vertex Pharmaceuticals in a report on Sunday, January 8th.

The Company has 247.35 million shares outstanding and 246.59 million shares were floated in market. One research analyst has rated the stock with a sell rating, thirteen have issued a hold rating and thirteen have issued a buy rating to the stock. The company has a consensus rating of "Hold" and a consensus price target of $100.88.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reached 29.25% versus a 1-year low price of $71.46. The stock had a trading volume of 124,491 shares.

EVP, Global Research and CSO, ALTSHULER DAVID, sold 6,403 common shares of Vertex Pharmaceuticals Incorporated (VRTX) in the open market. The third largest holder is Fmr Llc, which now holds $1.9 billion worth of this stock and that ownership represents almost 8.32% of its market capitalization. Investors who are keeping close eye on the stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) established that the company was able to keep return on investment at -4.47 in the trailing twelve month while Reuters data showed that industry's average stands at -3.19 and sector's optimum level is 12.94.

Vertex Pharmaceuticals (NASDAQ:VRTX) last released its quarterly earnings results on Wednesday, January 25th.

In the company's last quarter, Dean Foods Company (NYSE) EPS moved to $0.38 from $0.37 compared sequentially with the prior quarter. Well, according to what we could find, analysts had been looking for the company to post net income of about $0.41 per share on $2,018.90M in revenue. On average, equities research analysts anticipate that Vertex Pharmaceuticals Incorporated will post $1.62 EPS for the current fiscal year. The shares were sold at an average price of $74.33, for a total transaction of $483,145.00. Following the completion of the transaction, the director now directly owns 274,725 shares in the company, valued at $20,373,606. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

On 12/14/2016 Joshua S Boger, Director, sold 6,500 with an average share price of $77.52 per share and the total transaction amounting to $503,880.00. Following the completion of the sale, the director now directly owns 276,225 shares in the company, valued at $22,783,038. The disclosure for this sale can be found here. Mr. Gregg A. Tanner is now ranked as the number three insider in terms of representation on the cap table for the stock, holding 368,023 shares, valued at around $6900431.25 as of recent close. For the current quarter the stock has lowest EPS estimates of $0.23 and high estimate of $1.21.

A number of other institutional investors also recently made changes to their positions in VRTX. Price T Rowe Associates Inc. Norges Bank acquired a new position in Vertex Pharmaceuticals during the fourth quarter valued at about $127,564,000. Fox Run Management L.L.C. bought a new stake in Vertex Pharmaceuticals during the third quarter valued at $488,000. Creative Planning now owns 5,554 shares of the pharmaceutical company's stock valued at $484,000 after buying an additional 305 shares during the last quarter. State Street Corp raised its position in shares of Vertex Pharmaceuticals by 2.7% in the fourth quarter. Two Sigma Investments LP now owns 1,026,855 shares of the pharmaceutical company's stock valued at $75,648,000 after buying an additional 604,506 shares during the period. Institutional investors own 94.85% of the company's stock. Finally, BlackRock Fund Advisors raised its position in shares of Vertex Pharmaceuticals by 3.9% in the third quarter. WFG Advisors LP now owns 24,800 shares of the pharmaceutical company's stock valued at $2,188,000 after buying an additional 24,779 shares during the period.

Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. Its business is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications.


  • 'Stalker ex-boyfriend slit teenager's throat'

    Ms King added: "Shana said that he was bothering her, that he liked her and kept texting her and would not leave her alone". She said of Miss Grice: "She was lovely". "I got angry and one of the householders came out and she sorted it".

    Suri Cruise Looks So Much Like Young Katie Holmes Now

    Looking at the Suri's photos, people understand that the girl has inherited the features of both parents, not only Katie . She also noted that her nephews and her daughter inspire her with their "accomplishments and attractive hearts".

    Senator Menendez Rebuffed by Top Court on Corruption Charges

    Supreme Court on Monday declined to throw out the federal indictment against U.S. Menendez is accused of soliciting and accepting gifts from his friend, Dr.
  • Game Freak Recruitment Has People Hoping for "Pokémon" on Switch

    In an interview with Toyokeizai Online , Ishihara said it wouldn't be as simple as porting their games to the console. According to Game Freak, "It's a title that just about anyone knows, a proposal that could be your future career".

    Florida State beats Missouri to reach Sweet 16

    The Musketeers move on in the West region, marking the third straight year they have advanced to the second round. Inconsistency has been a problem all season for Florida State, and that was the case again tonight.

    Saints hosting quarterback Chase Daniel on free-agent visit

    The Jets met with Josh McCown over the weekend, but no deal was signed and their quarterback search will continue with another meeting on Monday.
  • Pope begs forgiveness for church role in Rwanda genocide

    The pope was speaking in a statement issued after "cordial" 25-minute talks with Rwandan President Paul Kagame in the Vatican. Francis said he had told Kagame he hoped his apology would help his country heal its wounds.

    Five Suspects Arrested in OR Tambo Heist

    As well as the suspect with the luxury vehicle , a further four people were arrested over the weekend, according to the BBC . The second arrest, of a 39-year old G4S security guard, occurred at Elandsfontein shortly afterwards, said the source.

    Brexit process set for March 29

    It comes as Mrs May dismissed calls for a second independence referendum for Scotland before the Brexit deal is finalised. The letter May sends next week will plunge Britain into a period of intense uncertainty.
  • Germany to Trump: We don't owe North Atlantic Treaty Organisation money

    I WATCHED, as many millions did, the television coverage of US President Donald Trump with German Chancellor Angela Merkel . It's still not clear who all of Napolitano's sources were, and Fox News has declined CNN's requests to elaborate.

    USC Tops Tennessee, 6-4 in 10 Innings

    Jonah Bride contributed an RBI single to bring in another run, then Alex Destino smacked a two-run double to make the score 6-1. The Tennessee response was immediate as pinch hitter Matt Waldren banged a one-out home run to left field to even it at 4-all.

    Leyton Orient winding-up petition adjourned until June

    Bosses at an events management firm said on Monday they were owed about £18,000 and wanted to launch a winding-up application. The League Two side were the subject of a winding-up petition brought by HM Revenue & Customs over unpaid taxes.